Clinical Trial Update: Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia [Phase 2]

View source ↗

Summary

The document reports the completion status of a Phase 2 pilot study evaluating CAT-2003 in patients with severe hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia
• Lipid Metabolism Disorders
• Metabolic Diseases

Drugs mentioned

• CAT-2003

Snippet

Sponsor: Catabasis Pharmaceuticals | Conditions: Hyperlipidemias, Hypertriglyceridemia | Phase 2 | Status: COMPLETED